(Q33998311)

30 July 2017

1 reference

title

Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. (English)

1 reference

30 July 2017

Frederick R. Appelbaum

series ordinal

2

object named as

Appelbaum FR

1 reference

30 July 2017

1

Deeg HJ

1 reference

PubMed ID

10936419

30 July 2017

language of work or name

1 reference

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

24

1 reference

30 July 2017

8

1 reference

30 July 2017

653-663

1 reference

Proposals for the classification of the myelodysplastic syndromes

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Stem cell transplantation and intensified cytotoxic treatment for myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. European Working Group on MDS in Childhood (EWOG-MDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Successful donor lymphocyte infusion (DLI) in a patient with myelodysplastic syndrome (MDS) after failure of T-cell-depleted bone marrow transplantation (TD-BMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Mixed chimerism: preclinical studies and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900049-7

7 January 2021

10.1016/S0145-2126(00)00049-7

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10936419